Ajanta Pharma files Q2 FY2026-27 earnings call transcript

Investor Communications View source PDF Explain this filing

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.2%Reaction day

₹3320.00

prior close

₹3282.20

announcement price

In-mkt

timing

Nifty Midcap 150market+1.6%-1.4% vs market

Pharmaceuticals peers, median of 173sector+0.8%-0.6% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Midcap 150 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

+0.2

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.2+1.6-1.4+0.8-0.6

Next day

-1.0+3.6-4.5+1.6-2.5

-0.6pendingpending+1.5-2.1

—————

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ajanta Pharma disclosed that the written transcript of its earnings call held on 30 October 2026 has been uploaded to its website. The filing was submitted on 4 November 2026 and does not include the transcript contents or any financial targets.

Likely market impact

The filing gives investors access to management's discussion but provides no new financial details or outlook that can be assessed directly.